Indivumed
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Falkenried Bldg D 88, Hamburg, Hamburg, ...Phone Number
+49 404133830Website
www.indivumed.comRevenue
$41.9 MillionIndustry
About Indivumed
Indivumed Org Chart
Is Indivumed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Indivumed recently announced quarterly report
Check out if Indivumed is spiking on competitors!
Click to see if Indivumed had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Indivumed has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Indivumed
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Indivumed has new funding data
Indivumed, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Indivumed launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Indivumed is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Indivumed is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Indivumed.
Indivumed financials insights
Gather financial insights about Indivumed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$48M
Indivumed Tech Stack
A closer look at the technologies used by Indivumed
Indivumed News & Media
Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
Two leading entities in cancer research pledge scientific collaboration to advance precision oncology. HAMBURG, Germany and ROCHESTER, N.Y., Dec. 10, 2025 /PRNewswire/ -- Indivumed is excited to announce its partnership with the world-renowned Wilmot Cancer Institute at the University of...Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics
Two leading entities in cancer research pledge scientific collaboration to advance precision oncology. HAMBURG, Germany and ROCHESTER, N.Y., Dec. 10, 2025 /PRNewswire/ -- Indivumed is excited to announce its partnership with the world-renowned Wilmot Cancer Institute at the University of Rochester Medical Center (URMC). Leveraging Indivumed's proven approach to standardized tissue and clinical data collection for patient-centric cancer R&D, this collaboration aims to accelerate the development oResearch Study from Indivumed Therapeutics Reveals a Path for the Discovery of New Targets and Development of Novel Cancer Therapies
HAMBURG, Germany--(BUSINESS WIRE)-- #biotech--A new research study reveals significant changes in the molecular characteristics of tumor samples just 10 minutes after surgical removal.Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
Sale of Indivumed's Service Business to Crown Bioscience Enables Creation of Oncology R&D Powerhouse HAMBURG, Germany, April 4, 2023 /PRNewswire/ -- After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics...
Top Business Services Companies
Frequently Asked Questions Regarding Indivumed
Indivumed is a biotechnology company focused on advancing precision oncology through the discovery and development of novel cancer therapeutics. They utilize a unique database of over 20 years of pre-analytically controlled tumor and normal tissue samples, combined with comprehensive clinical data, to identify and validate innovative cancer targets... Read More